Target intelligence / Profile preview

Helicobacter pylori proteins and adhesins (H. pylori proteins)

Target
H. pylori proteins
Molecular classification
Enzyme, Adhesin, Cytotoxin, Bacterial protein, Transporter
01

Overview

Helicobacter pylori proteins and adhesins represent a collective group of virulence factors and metabolic enzymes that enable the bacterium to survive and colonize the human gastric mucosa. A central component is Urease, an enzyme that catalyzes the hydrolysis of urea into ammonia and carbon dioxide, effectively neutralizing local gastric acid to create a habitable niche (StatPearls, 2023). Adhesins such as Blood group antigen-binding adhesin (BabA) and Sialic acid-binding adhesin (SabA) facilitate persistent colonization by binding to specific receptors on gastric epithelial cells (PubMed, 2021). Pathogenic strains often express Cytotoxin-associated gene A (CagA) and Vacuolating cytotoxin A (VacA), which manipulate host cell signaling, induce inflammation, and contribute to oncogenesis (UniProt, 2024). Therapeutic strategies primarily involve combination antibiotic regimens (e.g., clarithromycin, amoxicillin) that target bacterial protein synthesis and cell wall integrity, alongside proton pump inhibitors to enhance drug efficacy (NIH, 2023). These proteins are critical targets for both eradication of infection and the prevention of gastric cancer and peptic ulcers.

Other names
H. pylori virulence factorsHelicobacter pylori enzymesH. pylori adhesinsGastric bacterial proteins
02

Mechanism of action

Inhibition of bacterial cell wall synthesis, inhibition of protein synthesis (50S/30S ribosomal subunits), inhibition of DNA gyrase, and inhibition of urease activity to prevent acid neutralization.

03

Biological functions

Acid neutralizationBacterial adhesionHost cell apoptosisImmune evasionInflammation inductionProtein synthesis
04

Disease associations

GastritisPeptic ulcer diseaseGastric adenocarcinomaMALT lymphomaInfection
05

Safety considerations

Emergence of multi-drug resistant H. pylori strainsDisruption of the commensal gut microbiomeSystemic side effects of combination antibiotic therapyPotential for reinfection
06

Interacting drugs

Amoxicillin

7 more in the full profile.

07

Biomarkers

Urea breath test (UBT)Stool antigen testRapid urease test (RUT)Anti-CagA antibodiesAnti-VacA antibodies

Beyond the preview

Go deeper on Helicobacter pylori proteins and adhesins (H. pylori proteins).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helicobacter pylori proteins and adhesins (H. pylori proteins).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call